IDC: Market share of core diagnosis and treatment systems in Chinese hospitals in 2022

IDC recently released "China's Hospital Core Diagnosis and Treatment System Market Share, 2022: New Generation Systems Become Mainstream" (IDC #CHC49148323, July 2023). This report gives the market share of major manufacturers of China's hospital core diagnosis and treatment systems (hereinafter referred to as "core systems"), analyzes the competitive situation of the hospital core system market, and analyzes and evaluates the market performance of leading manufacturers in 2022. It can be used as a reference for hospitals when selecting suppliers of hospital core diagnosis and treatment systems, as well as for investment institutions, and as a reference for comprehensive IT manufacturers when selecting partners.

The new generation of hospital core systems has become mainstream

In 2022, the hospital core system market was affected by the widespread COVID-19 epidemic. The construction of core system projects in some hospitals was delayed, the growth rate of the core system market declined, and related manufacturers were generally affected to varying degrees. It has been seven years since the concept of hospital core system was proposed in 2016. During this period, many manufacturers have developed core systems with integrated architectures. These systems have been continuously upgraded and iterated in practice, becoming increasingly mature in terms of functions and technologies, and gradually forming a "new generation" of hospital core systems.

The new generation of hospital core systems are mainly reflected in the following three characteristics:

• From a technical perspective, the new generation of systems is designed with an integrated architecture concept, and the data middle platform has been widely used.
• Product functions continue to increase in the areas of smart healthcare, smart management, and smart services.
• Cloud native technologies such as microservices and containerization have been deeply applied, and cloud deployment of core systems has become a trend.

At the same time, medical reform continues to advance, driving the continuous development of core systems. The rating of electronic medical record application level and hospital information interconnection and interoperability assessment continue to be carried out, and a mature evaluation and assessment mechanism has been formed in many provinces to promote the upgrading of core systems in hospitals at all levels. The new policies of the medical reform policy, such as the improvement of hospital operation management and medical insurance reform caused by the high-quality development of hospitals, are also driving the upgrading of hospital core systems. At the same time, the construction of hospital HRP, DRG/DIP and other systems is also promoting the upgrading and improvement of core systems.

Mature core system products and efficient deployment and operation and maintenance mechanisms are becoming the key to manufacturers gaining competitive advantage

Hospital core system vendors are striving to seize the development momentum of the new generation of systems and expand their core system businesses. Leading vendors already have basically mature core systems, and their deployment speed has significantly accelerated. They are able to actively grasp existing hospital customer resources, continue to meet the various upgrade needs of old customers, and strive to expand the hospital market at all levels and regions.

Those manufacturers who have established mature new-generation core systems have rich product functions, adopted advanced information technology, and gradually established efficient system delivery, deployment and maintenance processes, so that they are better able to withstand market fluctuations and continue to improve; some manufacturers need to continuously improve their capabilities in the core system's technology adoption, function expansion, delivery, deployment and operation and maintenance in order to adapt to future development needs.

The market share of major manufacturers of core diagnosis and treatment systems in Chinese hospitals in 2022 is shown in the following figure: